LAPATINIB IN BREAST CANCER - THE PREDICTIVE SIGNIFICANCE OF HER1 (EGFR), HER2, PTEN AND PIK3CA GENES AND LAPATINIB PLASMA LEVEL ASSESSMENT-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LAPATINIB IN BREAST CANCER - THE PREDICTIVE SIGNIFICANCE OF HER1 (EGFR), HER2, PTEN AND PIK3CA GENES AND LAPATINIB PLASMA LEVEL ASSESSMENT

Published:2010-12-01 Issue:4 Volume:154 Page:281-288
ISSN:1213-8118
Container-title:Biomedical Papers
language:
Short-container-title:BIOMED PAP

Author:

Bouchalova Katerina,Cizkova Magdalena,Cwiertka Karel,Trojanec Radek,Friedecky David,Hajduch Marian

Publisher

Palacky University Olomouc

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://biomed.papers.upol.cz/doi/10.5507/bp.2010.043.pdf

Reference104 articles.

1. Nighttime light level co-distributes with breast cancer incidence worldwide

2. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute.

3. Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases

4. Triple negative breast cancer - current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment

5. Emerging Targeted Therapies for Breast Cancer

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New pyrazolo[3,4-d]pyrimidine derivatives as EGFR-TK inhibitors: design, green synthesis, potential anti-proliferative activity and P-glycoprotein inhibition;RSC Advances;2024

2. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario;Pharmaceutics;2023-02-16

3. Fragment-based Discovery of Potential Anticancer Lead: Computational and in vitro Studies;Current Computer-Aided Drug Design;2021-07-15

4. Structural-based design, synthesis, and antitumor activity of novel alloxazine analogues with potential selective kinase inhibition;European Journal of Medicinal Chemistry;2018-05

5. Design, synthesis and evaluation of azaacridine derivatives as dual-target EGFR and Src kinase inhibitors for antitumor treatment;European Journal of Medicinal Chemistry;2017-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3